V Square Quantitative Management LLC Alkermes Plc. Call Options Transaction History
V Square Quantitative Management LLC
- $681 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
350Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$843 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$579 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$416 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$319 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$267 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.76B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...